Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company that focuses on combining immunologic insights with technologies to treat and prevent serious infectious diseases. The company was founded in 2016 and is headquartered in San Francisco, California.
Last updated on
About Vir Biotechnology
Founded
2016Estimated Revenue
$1B-$10BEmployees
251-1KFunding / Mkt. Cap
$794MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
28NAICs Code
32Location
City
San FranciscoState
CaliforniaCountry
United StatesTech Stack (88)
